Secreted frizzled-related protein 5 serum levels in human periodontitis-A nested case-control study.


Journal

Journal of clinical periodontology
ISSN: 1600-051X
Titre abrégé: J Clin Periodontol
Pays: United States
ID NLM: 0425123

Informations de publication

Date de publication:
05 2019
Historique:
received: 12 03 2018
revised: 04 12 2018
accepted: 09 02 2019
pubmed: 15 2 2019
medline: 18 12 2019
entrez: 15 2 2019
Statut: ppublish

Résumé

Recombinant secreted frizzled-related protein 5 (sFRP5) improved periodontal status in mice. Thus, this study aimed to investigate this finding in human periodontitis using an epidemiological approach. sFRP5 and wnt5a concentrations were determined in human serum from the Food Chain Plus cohort using ELISAs. A total of 128 patients with periodontitis and tooth loss and 245 patients with periodontitis without tooth loss were compared to 373 sex-, smoker-, age- and BMI-matched individuals in a nested case-control design. Systemic sFRP5 serum levels were significantly lower in patients with periodontitis and tooth loss (2.5 [0.0-10.4] ng/ml, median [IQR]) compared to patients with periodontitis without tooth loss (6.0 [2.5-15.8] ng/ml, median [IQR], p = 0.04] and matched controls (7.0 [2.5-18.3] ng/ml, median [IQR], p = 0.02). No significant differences in sFRP5 serum levels were found among patients with periodontitis without tooth loss (6.0 [2.5-15.8] ng/ml, median [IQR]) and controls (3.1 [0.0-10.6] ng/ml, median [IQR], p = 0.06). sFRP5 might serve as a novel biomarker for periodontitis severity. Modulating the inflammatory background of severe forms of periodontitis, in the time of precision medicine, needs to be revealed in further studies.

Identifiants

pubmed: 30762911
doi: 10.1111/jcpe.13087
doi:

Substances chimiques

Eye Proteins 0
Intracellular Signaling Peptides and Proteins 0
Membrane Proteins 0
WD repeat containing planar cell polarity effector 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

522-528

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Juliane Schulz (J)

Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany.
Clinic of Conservative Dentistry and Periodontology, University of Kiel, Kiel, Germany.

Carina Knappe (C)

Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany.

Christian Graetz (C)

Clinic of Conservative Dentistry and Periodontology, University of Kiel, Kiel, Germany.

Louisa Mewes (L)

Clinic of Conservative Dentistry and Periodontology, University of Kiel, Kiel, Germany.

Kathrin Türk (K)

Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany.

Anna K Black (AK)

Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany.

Wolfgang Lieb (W)

Institute of Epidemiology, Christian-Albrechts-University Kiel, Kiel, Germany.

Arne S Schäfer (AS)

Department of Periodontology and Synoptic Dentistry, Institute of Dental, Oral and Maxillary Medicine, Charité - University Medicine Berlin, Berlin, Germany.

Karim M Fawzy El-Sayed (KM)

Clinic of Conservative Dentistry and Periodontology, University of Kiel, Kiel, Germany.
Oral Medicine and Periodontology Department, Faculty of Oral and Dental Medicine, Cairo University, Giza, Egypt.

Christof E Dörfer (CE)

Clinic of Conservative Dentistry and Periodontology, University of Kiel, Kiel, Germany.

Stefan Schreiber (S)

Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany.
Cluster of Excellence, Inflammation at Interfaces, Christian-Albrechts-University Kiel, Kiel, Germany.

Matthias Laudes (M)

Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany.
Cluster of Excellence, Inflammation at Interfaces, Christian-Albrechts-University Kiel, Kiel, Germany.

Dominik M Schulte (DM)

Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany.
Cluster of Excellence, Inflammation at Interfaces, Christian-Albrechts-University Kiel, Kiel, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH